Safety, pharmacokinetics, pharmacodynamics and clinical activity of KT-333, a targeted protein degrader of STAT3, in patients with relapsed or refractory lymphomas, leukemia, and solid tumors Meeting Abstract
| Authors: | Feldman, T.; Marchi, E.; Smith, S. D.; Olszewski, A. J.; Huen, A. O.; Epstein-Peterson, Z. D.; Stevens, D. A.; Starodub, A. N.; Feldman, E. J.; Rodriguez, C. P.; Reneau, J. C.; Brammer, J. E.; Mattour, A. H.; Pinter-Brown, L. C.; Perea, R.; Henrick, P.; Dey, J.; Fasciano, A.; Karnik, R.; Agarwal, S.; Gollerkeri, A.; Gollob, J.; Shastri, A.; Barta, S. K. |
| Abstract Title: | Safety, pharmacokinetics, pharmacodynamics and clinical activity of KT-333, a targeted protein degrader of STAT3, in patients with relapsed or refractory lymphomas, leukemia, and solid tumors |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 4433 |
| Language: | English |
| ACCESSION: | WOS:001410587900018 |
| DOI: | 10.1182/blood-2024-210301 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
